71 related articles for article (PubMed ID: 20795350)
41. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
42. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
Eisenkop SM; Friedman RL; Wang HJ
Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
[TBL] [Abstract][Full Text] [Related]
43. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
[TBL] [Abstract][Full Text] [Related]
44. Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
Kim JJ; Park JY; Kim DY; Kim JH; Kim YM; Nam JH; Kim YT
Acta Obstet Gynecol Scand; 2010 May; 89(5):623-8. PubMed ID: 20423275
[TBL] [Abstract][Full Text] [Related]
45. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
Laframboise S; Chapman W; McLaughlin J; Andrulis IL
Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
[TBL] [Abstract][Full Text] [Related]
46. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
47. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic factors of epithelial ovarian cancer in young women].
Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
[TBL] [Abstract][Full Text] [Related]
49. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
50. Extreme drug resistance assay results do not influence survival in women with epithelial ovarian cancer.
Karam AK; Chiang JW; Fung E; Nossov V; Karlan BY
Gynecol Oncol; 2009 Aug; 114(2):246-52. PubMed ID: 19500821
[TBL] [Abstract][Full Text] [Related]
51. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS
Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277
[TBL] [Abstract][Full Text] [Related]
52. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
53. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
[TBL] [Abstract][Full Text] [Related]
54. Impact of statin therapy on survival in epithelial ovarian cancer.
Elmore RG; Ioffe Y; Scoles DR; Karlan BY; Li AJ
Gynecol Oncol; 2008 Oct; 111(1):102-5. PubMed ID: 20698078
[TBL] [Abstract][Full Text] [Related]
55. DNA-ploidy as an independent prognostic factor in patients with serous ovarian carcinoma.
But I; Gorisek B
Int J Gynaecol Obstet; 2000 Dec; 71(3):259-62. PubMed ID: 11102619
[No Abstract] [Full Text] [Related]
56. Aspirin use correlates with survival in women with clear cell ovarian cancer.
Wield AM; Walsh CS; Rimel BJ; Cass I; Karlan BY; Li AJ
Gynecol Oncol Rep; 2018 Aug; 25():78-81. PubMed ID: 29922710
[TBL] [Abstract][Full Text] [Related]
57. Smoking and cancer of the ovary.
Hellberg D; Nilsson S
N Engl J Med; 1988 Mar; 318(12):782-3. PubMed ID: 3347230
[No Abstract] [Full Text] [Related]
58. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
Praestegaard C; Jensen A; Jensen SM; Nielsen TS; Webb PM; Nagle CM; DeFazio A; ; Høgdall E; Rossing MA; Doherty JA; Wicklund KG; Goodman MT; Modugno F; Moysich K; Ness RB; Edwards R; Matsuo K; Hosono S; Goode EL; Winham SJ; Fridley BL; Cramer DW; Terry KL; Schildkraut JM; Berchuck A; Bandera EV; Paddock LE; Massuger LF; Wentzensen N; Pharoah P; Song H; Whittemore A; McGuire V; Sieh W; Rothstein J; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Wu AH; Pearce CL; Pike M; Lee AW; Sutphen R; Chang-Claude J; Risch HA; Kjaer SK;
Int J Cancer; 2017 Jun; 140(11):2422-2435. PubMed ID: 28063166
[TBL] [Abstract][Full Text] [Related]
59. Effect of cigarette smoking on epithelial ovarian cancer survival.
Ioffe YJ; Elmore RG; Karlan BY; Li AJ
J Reprod Med; 2010; 55(7-8):346-50. PubMed ID: 20795350
[TBL] [Abstract][Full Text] [Related]
60. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
